Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Key Takeaways
- Full and open competition - all businesses eligible to bid
- Work to be performed in Washington, DC
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- ARPA-H-SOL-26-164
- Opportunity Type
- Solicitation
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
- Posted Date
- Wednesday, September 30, 2026
- Response Deadline
- Monday, November 30, 2026
- PSC Code
- AN13
- Set-Aside
- Full & Open Competition
- Place of Performance
- Washington, DC, 20005
- Status
- Active
Description
The Advanced Research Projects Agency for Health (ARPA-H) posts this solicitation in support of its Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) Program. ARPA-H anticipates multiple Other Transaction Agreement awards will result from this opportunity. Interested parties are invited to review the attached Solicitation (ARPA-H-SOL-26-164) and associated attachments. As detailed in Special Notice ARPA-H-SN-26-164, ARPA-H will host an informational webinar on 15 OCT 2026 and a 2-day Proposers Day on 6 and 9 NOV 2026 in support of SURPASS. All questions related to SURPASS should be submitted to SURPASS@ARPA-H.GOV.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) in Washington, DC.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
